AHR and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, we further investigated the expression of AHR, the key transcription factor directing Th22 lineage commitment, and found that AHR mRNA expression also significantly decreased in PB and BM of ND CML patients.